OR WAIT null SECS
Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.
January 03, 2022
An obvious theme for 2021 has been COVID-19, but the next 12 months will see industry and its people experiencing further change.
Poor solubility remains a big issue for drug development and, as such, is driving innovation in approaches and use of novel technologies to help overcome the associated challenges.
January 02, 2022
Overall, 2021 proved to be another good year for drug approvals in Europe, albeit with a slight disappointment for Alzheimer’s patients, but what should industry be watching out for in 2022?
December 03, 2021
Increased patient-centricity and alternative dosage forms require careful consideration when selecting the best taste-masking approach.
December 02, 2021
Particle analysis is a critical component of pharmaceutical development, providing assurances of the quality and performance of the final dosage form.
Pharma and biotech are ruling the roost in terms of university innovation, but European spinouts are still experiencing barriers to long-term success.